122 related articles for article (PubMed ID: 8773464)
21. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
Richfield EK
Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
Zhu J; Mactutus CF; Wallace DR; Booze RM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
[TBL] [Abstract][Full Text] [Related]
23. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
[TBL] [Abstract][Full Text] [Related]
24. Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6.
Hiroi T; Imaoka S; Chow T; Yabusaki Y; Funae Y
Biochem Pharmacol; 1997 Jun; 53(12):1937-9. PubMed ID: 9256169
[TBL] [Abstract][Full Text] [Related]
25. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex.
Andersen PH
J Neurochem; 1987 Jun; 48(6):1887-96. PubMed ID: 2952763
[TBL] [Abstract][Full Text] [Related]
27. Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion.
Wu Q; Coffey LL; Reith ME
J Neurochem; 1997 Sep; 69(3):1106-18. PubMed ID: 9282933
[TBL] [Abstract][Full Text] [Related]
28. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
Madras BK; Reith ME; Meltzer PC; Dutta AK
Eur J Pharmacol; 1994 Apr; 267(2):167-73. PubMed ID: 8050478
[TBL] [Abstract][Full Text] [Related]
29. Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935.
Govitrapong P; Vilaipun P; Ebadi M
J Pineal Res; 2003 Aug; 35(1):16-23. PubMed ID: 12823609
[TBL] [Abstract][Full Text] [Related]
30. Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum.
Collins LM; Meyer JS
Synapse; 1996 Aug; 23(4):335-43. PubMed ID: 8855519
[TBL] [Abstract][Full Text] [Related]
31. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
Régo JC; Syringas M; Leblond B; Costentin J; Bonnet JJ
Br J Pharmacol; 1999 Sep; 128(1):51-60. PubMed ID: 10498834
[TBL] [Abstract][Full Text] [Related]
32. Chronic blockade of opioid receptors alters the binding of [3H]GBR 12935 to dopamine transporter in rat brain regions and spinal cord.
Bhargava HN; Gudehithlu KP
Pharmacology; 1996 Apr; 52(4):243-51. PubMed ID: 8841087
[TBL] [Abstract][Full Text] [Related]
33. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
Bonnet JJ; Protais P; Chagraoui A; Costentin J
Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a recombinant human dopamine transporter in multiple cell lines.
Eshleman AJ; Neve RL; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
[TBL] [Abstract][Full Text] [Related]
35. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
Gordon I; Weizman R; Rehavi M
Eur J Pharmacol; 1996 Feb; 298(1):27-30. PubMed ID: 8867915
[TBL] [Abstract][Full Text] [Related]
36. [3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors.
Gordon I; Weizman R; Rehavi M
Life Sci; 1994; 55(3):189-99. PubMed ID: 8007761
[TBL] [Abstract][Full Text] [Related]
37. Modification of the characteristics of dopamine transporter in brain regions and spinal cord of morphine tolerant and abstinent rats.
Gudehithlu KP; Bhargava HN
Neuropharmacology; 1996 Feb; 35(2):169-74. PubMed ID: 8734485
[TBL] [Abstract][Full Text] [Related]
38. Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways.
Izenwasser S; Werling LL; Rosenberger JG; Cox BM
Neuropharmacology; 1990 Nov; 29(11):1017-24. PubMed ID: 2087254
[TBL] [Abstract][Full Text] [Related]
39. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
Akunne HC; Dersch CM; Cadet JL; Baumann MH; Char GU; Partilla JS; de Costa BR; Rice KC; Carroll FI; Rothman RB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1462-75. PubMed ID: 7908058
[TBL] [Abstract][Full Text] [Related]
40. Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.
Dutta AK; Coffey LL; Reith ME
J Med Chem; 1997 Jan; 40(1):35-43. PubMed ID: 9016326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
